Total Payments
$43,004
2024 Payments
$2,370
Companies
43
Transactions
909
Medicare Patients
1,459
Medicare Billing
$237,344
Payment Breakdown by Category
Food & Beverage$30,000 (69.8%)
Other$10,000 (23.3%)
Travel$2,445 (5.7%)
Consulting$500.00 (1.2%)
Education$59.44 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $30,000 | 887 | 69.8% |
| Honoraria | $10,000 | 8 | 23.3% |
| Travel and Lodging | $2,445 | 4 | 5.7% |
| Consulting Fee | $500.00 | 1 | 1.2% |
| Education | $59.44 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $14,902 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,752 | 64 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $3,719 | 56 | $0 (2024) |
| Novo Nordisk Inc | $3,554 | 224 | $0 (2024) |
| Amgen Inc. | $2,898 | 61 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,204 | 42 | $0 (2023) |
| Lilly USA, LLC | $1,637 | 98 | $0 (2024) |
| ABBVIE INC. | $1,579 | 55 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,134 | 25 | $0 (2023) |
| PFIZER INC. | $1,092 | 39 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,370 | 56 | AstraZeneca Pharmaceuticals LP ($409.75) |
| 2023 | $3,398 | 71 | Kowa Pharmaceuticals America, Inc. ($652.54) |
| 2022 | $10,291 | 68 | Kowa Pharmaceuticals America, Inc. ($6,980) |
| 2021 | $3,442 | 119 | Janssen Pharmaceuticals, Inc ($616.85) |
| 2020 | $1,748 | 84 | Novo Nordisk Inc ($293.01) |
| 2019 | $6,550 | 156 | Kowa Pharmaceuticals America, Inc. ($2,446) |
| 2018 | $6,598 | 179 | Kowa Pharmaceuticals America, Inc. ($1,232) |
| 2017 | $8,608 | 176 | Kowa Pharmaceuticals America, Inc. ($3,247) |
All Payment Transactions
909 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $118.46 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $99.15 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $32.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $87.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $103.84 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $97.12 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: Obesity | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: Inflammation | ||||||
| 08/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $58.19 | General |
| Category: Respiratory | ||||||
| 06/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 76 | 170 | $47,352 | $17,273 |
| 2022 | 1 | 19 | 72 | $14,400 | $7,479 |
| 2021 | 9 | 560 | 1,585 | $178,515 | $110,056 |
| 2020 | 9 | 804 | 2,282 | $201,731 | $102,536 |
Total Patients
1,459
Total Services
4,109
Medicare Billing
$237,344
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 170 | $47,352 | $17,273 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 72 | $14,400 | $7,479 | 51.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 827 | $132,320 | $82,195 | 62.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 237 | $24,885 | $14,231 | 57.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 69 | $13,662 | $9,777 | 71.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 15 | 15 | $2,250 | $2,206 | 98.1% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 70 | 179 | $2,148 | $703.47 | 32.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 107 | 203 | $1,827 | $609.00 | 33.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 15 | 16 | $960.00 | $173.55 | 18.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 22 | 28 | $364.00 | $112.56 | 30.9% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 11 | 11 | $99.00 | $48.18 | 48.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 166 | 865 | $138,400 | $72,273 | 52.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 137 | 344 | $36,120 | $16,954 | 46.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 41 | 41 | $6,150 | $5,246 | 85.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 27 | $5,346 | $3,140 | 58.7% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 121 | 352 | $4,224 | $1,374 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 147 | 412 | $3,708 | $1,227 | 33.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 59 | 88 | $3,256 | $1,166 | 35.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 48 | 54 | $3,240 | $760.48 | 23.5% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 67 | 99 | $1,287 | $395.02 | 30.7% |
About Dr. Jack Goldman, M.D
Dr. Jack Goldman, M.D is a Internal Medicine healthcare provider based in Auburn, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023065539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Goldman, M.D has received a total of $43,004 in payments from pharmaceutical and medical device companies, with $2,370 received in 2024. These payments were reported across 909 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($30,000).
As a Medicare-enrolled provider, Goldman has provided services to 1,459 Medicare beneficiaries, totaling 4,109 services with total Medicare billing of $237,344. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Specialist
- Location Auburn, WA
- Active Since 05/28/2006
- Last Updated 01/05/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023065539
Products in Payments
- Livalo (Drug) $8,124
- XARELTO (Drug) $2,826
- FARXIGA (Drug) $2,234
- JARDIANCE (Drug) $1,588
- Ozempic (Drug) $1,487
- Repatha (Biological) $1,172
- ENTRESTO (Drug) $1,134
- VRAYLAR (Drug) $1,017
- PRALUENT (Drug) $657.33
- UBRELVY (Drug) $653.55
- INVOKANA (Drug) $646.12
- TRULICITY (Drug) $633.14
- Otezla (Drug) $543.06
- Aimovig (Biological) $518.50
- BREZTRI (Drug) $469.69
- TRELEGY ELLIPTA (Drug) $431.27
- CHANTIX (Drug) $418.88
- Vascepa (Drug) $418.67
- NURTEC ODT (Drug) $413.45
- BYDUREON (Drug) $387.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Auburn
Dr. Mythili Ramachandran, M.d, M.D
Internal Medicine — Payments: $20,709
Internal Medicine $20,709
Dr. Jang Chi, Md, MD
Internal Medicine — Payments: $17,477
Internal Medicine $17,477
Edwin Young, D.o, D.O
Internal Medicine — Payments: $13,747
Internal Medicine $13,747
Steven Rozak, M.d, M.D
Internal Medicine — Payments: $13,344
Internal Medicine $13,344
Frances Jensen, M.d, M.D
Internal Medicine — Payments: $9,223
Internal Medicine $9,223
Dr. Mark Mcswain, M.d, M.D
Internal Medicine — Payments: $6,100
Internal Medicine $6,100